Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

St. Jude Announces First Implant In Trial Evaluating AMPLATZER Cardiac Plug

RELATED NEWS
Trade STJ now with 

Medical device company St. Jude Medical Inc. (STJ: Quote) Friday announced the first patient implant in a new trial evaluating the company's AMPLATZER Cardiac Plug or ACP for the prevention of stroke. The company said the AMPLATZER Cardiac Plug Clinical Trial is designed to determine the safety and effectiveness of the ACP device in preventing blood clots from migrating out of the left atrial appendage in patients with non-valvular atrial fibrillation who have a high risk for stroke.

The implant was performed by Dr. Christian Machado, director of electrophysiology at the Providence Hospital Heart Institute, Southfield, Michigan, and investigator in the study.

Explaining the need for the trial, Dr. James Hermiller, an interventional cardiologist from St. Vincent Hospital in Indianapolis and ACP Trial investigator said, "The current standard of care for the prevention of stroke is warfarin or other oral blood-thinning medications that can be difficult for some people to tolerate, and may carry a risk of serious complications, such as bleeding.."

Commenting on the development, Frank Callaghan, president of the St. Jude Medical Cardiovascular and Ablation Technologies Division said, "The AMPLATZER Cardiac Plug has shown great promise in international markets and we look forward to establishing the evidence required to make it available in the U.S."

Register
To receive FREE breaking news email alerts for St. Jude Medical Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Computer and printer maker Hewlett-Packard Co. (HPQ) said Wednesday after the markets closed that its third quarter profit fell 29% from last year, hurt mainly by higher restructuring charges even as revenue grew 1%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue beat analysts' forecast. Stocks fluctuated over the course of the trading day on Wednesday before ending the session mostly higher. The Dow and the S&P 500 both finished the day in positive territory, although the tech-heavy Nasdaq posted a modest loss. President Barack Obama spoke harshly of the terrorist group allegedly responsible for the execution of American freelance journalist James Foley in a statement on Wednesday. Obama described the group known as the Islamic State of Iraq and the Levant, or ISIL, as a cancer that needs to be extracted.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.